Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Korea SE
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Hanall Biopharma Co Ltd

+ Add to Watchlist

009420:KS

7,120 KRW 180 2.47%

As of 02:23:49 ET on 05/24/2013.

Company Profile for Hanall Biopharma Co Ltd (009420)

HANALL BIOPHARMA CO., LTD. manufactures prescription drugs for hospitals. The Company specializes in making oral and non-oral antibiotics and amino-acid infusions.

Contact Information

Hanall Biopharma Co Ltd

400-1 Sangseo-dong
Daedeok-gu
Daejeon, 306-120
Korea, Republic of (South)
Phone: 82-42-932-5997
Fax: 82-42-932-6427

Key Executives for Hanall Biopharma Co Ltd (009420)

Kim Seong-UkPresident/CEO/Rep DirectorChoe Seong-JunVice President
Jo Nam-YongSenior Managing DirectorLee Han-SuManaging Director
Kim Seong-JinManaging DirectorPark Seung-GukExecutive Director
Min Chang-HuiExecutive DirectorLee Sun-ImExecutive Director

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil